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LCI is a type of novel antibacterial polypeptide secreted by a Bacillus
subtilis strain. It consists of 47 residues with a molecular weight of
5468 Da. Using bioengineering, LCI was expressed in Escherichia coli
DH5 with recombinant plasmid pBVAB16. It was crystallized using
PEG 4000 as a precipitant. The crystal belongs to space group P6222
or P6422, with unit-cell parameters a = b = 29.30, c = 187.09 AÊ , and
diffracts to 2.44 AÊ . A set of diffraction data to 2.8 AÊ was collected.
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1. Introduction
Antibacterial proteins are a class of very
important proteins that exist widely in the
bodies or secretions of plants (Roberts &
Selitrennikoff, 1986), microorganisms (Von
Tersch & Carlton, 1983), insects (Okada &
Natori, 1985) and animals (Scheit et al., 1985).
Liu et al. (1990) screened and isolated a
B. subtilis strain (named A014) whose secre-
tions possess very strong antibacterial activ-
ities, especially against the pathogen
(Xanthomonas campestris pv. oryzea) of rice
leaf-blight disease, which is a serious threat to
rice production and causes great losses in
yields in most rice ®elds annually. Until now,
there has been no ef®cient method to control
this disease. It was found that the antibacterial
functions are carried out by several types of
protein in the secretions (Liu et al., 1991, 1992,
1993). The proteins are named LCI (Liu et al.,
1990), LCII (Liu et al., 1992) and LCIII (Liu et
al., 1993), respectively, according to the order
of their elution peaks from a CM-52 chroma-
tographic column. The sequence of LCI was
determined by protein sequencing. LCI
consists of 47 residues, with a molecular weight
of 5468 and a pI of 10.25. No homologous
protein was found in the protein information
resources the Protein Sequence Database
(PIR-PSD) and the Protein Data Bank (PDB).
After incubation for 20 min at 333, 353 or
373 K, LCI retains 100, 85.3 or 12.5% of its
antibacterial activity, respectively (Liu et al.,
1990), indicating that LCI is thermostable and
that its three-dimensional structure may be
highly stable, although there is no cysteine in
its sequence and hence no disul®de bonds in
the structure. Owing to the low yield of LCI
secreted by wild B. subtilis A014, it is dif®cult
to carry out crystallographic studies. Recently,
LCI was expressed in large quantities with an
E. coli expression system using DH5 with the
recombinant plasmid pBVAB16 in our
laboratory. Its molecular weight is 5464 Da as
measured by mass spectrometry and it shows
comparable thermal stability and antibacterial
activities to the native protein (to be published
elsewhere). The present work reports the
crystallization and preliminary crystallographic
studies of the antibacterial polypeptide LCI
expressed by engineering E. coli. with DH5.
Study of its three-dimensional structure will be
helpful in revealing the mechanisms of its
antibacterial activities and the thermal stability
for the protein.
2. Methods and results
Crystallization was carried out using the
hanging-drop vapour-diffusion method at
293 K. A 11 ml droplet containing 3.64 mg mlÿ1
LCI, 3.09%(w/v) PEG 4000, 0.55%(v/v)
dioxane and 0.01 M NaOAc±HOAc buffer pH
5.7 was equilibrated against 0.4 ml reservoir
solution containing 34%(w/v) PEG 4000 in
double-distilled water. Crystals were obtained
with maximum dimensions of 0.3  0.1 
0.1 mm after 7±10 d (Fig. 1). Only twin crystals
were obtained in the absence of dioxane in the
droplet. A crystal was mounted in a glass
capillary and X-ray diffraction data were
collected on a MAR 345 image-plate system
using Cu K ( = 1.5418 AÊ ) radiation from a
sealed-tube generator operated at 50 kV and
40 mA with a crystal-to-detector distance of
200 mm. The data were collected at 293 K. The
scan range was 90 with an oscillation of 1.
The data were processed using the programs
DENZO and SCALEPACK (Otwinowski &
Minor, 1997). The crystal diffracts to 2.44 AÊ
and the effective resolution is 2.8 AÊ . A total of
27 210 observations of 1506 unique re¯ections
within the resolution range 30.0±2.80 AÊ were
collected with an Rmerge of 10.9% (35.9% in the
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highest resolution shell 2.87±2.80 AÊ ) and a
multiplicity of 7.65 (7.47 in the highest
resolution shell 2.87±2.80 AÊ ). The comple-
teness of the overall data set is 99.8%
(100.0% in the highest resolution shell
2.87±2.80 AÊ ). The percentage of the overall
data set with I > 3(I) is 85.2% and with
I > 2(I) is 89.1%. The crystal belongs to one
of the enantiomorphous space groups P6222
or P6422. The unit-cell parameters are
a = b = 29.30, c = 187.09 AÊ , with a 2 of
0.751. Assuming one LCI molecule per
asymmetric unit cell, the calculated VM is
2.12 AÊ 3 Daÿ1, corresponding to a solvent
content of 39.7% (Matthews, 1968). The
values lie within the normal range for
protein crystals. As there is no homologous
protein available whose three-dimensional
structure has been determined, the
preparation of heavy-atom derivatives and
further crystallographic studies are under
way.
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Figure 1
The crystal of antibacterial polypeptide LC1
expressed in E. coli. The longest dimension is
approximately 0.3 mm.
